EE158 Budget Impact of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder from a US Payer Perspective

Autor:	M Doane, AK O'Sullivan, K Ottino, C Eichten
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S365
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.04.407
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6117724293480a2c8bf8e1d5df1ddcc3 https://doi.org/10.1016/j.jval.2022.04.407 Zobrazit plný text záznamu Full Text from ScienceDirect